Suppr超能文献

通过显微注射磷蛋白对RNA聚合酶II进行选择性抑制。

Selective repression of RNA polymerase II by microinjected phosvitin.

作者信息

Egyházi E, Pigon A

出版信息

Chromosoma. 1986;94(5):329-36. doi: 10.1007/BF00328632.

Abstract

We have used a microinjection technique to examine whether injected phosvitin, in its capacity as substrate for casein kinase NII, could compete out the endogenous phosphorylation of some nuclear phosphoproteins with regulatory potential and thereby interfere with the activity of RNA polymerase II. Phosphorylation, which utilizes ATP as phosphate donor, was separated from phosphorylation which uses GTP. Phosvitin introduced into nuclei of salivary gland cells becomes phosphorylated by the endogenous nuclear protein kinase(s) and incorporates phosphates from ATP as well as from GTP. The phosphorylation of nuclear proteins and phosvitin is heparin-sensitive, indicating that they are phosphorylated by casein kinase NII. Microinjected phosvitin does not seem to affect the incorporation of phosphate groups from ATP into nuclear proteins, but protein phosphorylation by GTP is influenced. Apart from a minor overall reduction of 32P-incorporation, the phosphorylation of a 42 kDa nuclear protein, a putative transcription stimulatory factor, and of a 115 kDa nuclear protein was competed out by 70%-80% compared with the control value obtained in the absence of phosvitin. Parallel analyses of DNA transcription in phosvitin-injected nuclei showed that the RNA polymerase II-mediated synthesis of hnRNA and Balbiani ring RNA was diminished by 80% and 90%, respectively. In contrast, the transcription of nucleolar pre-ribosomal 38 S RNA by RNA polymerase I remained unaffected. The inhibitory effect of injected phosvitin could be reversed by in vitro phosphorylation of phosvitin prior to injection, using isolated nuclei as source of protein kinase(s). Taken together, the results suggest a causal relationship between the modification of the GTP-dependent phosphorylation of specific non-histone proteins and the activity of RNA polymerase II.

摘要

我们采用了显微注射技术来研究注射的磷蛋白(作为酪蛋白激酶NII的底物)是否能够竞争某些具有调节潜能的核磷蛋白的内源性磷酸化,从而干扰RNA聚合酶II的活性。利用ATP作为磷酸供体的磷酸化与利用GTP的磷酸化被区分开来。引入唾液腺细胞核中的磷蛋白会被内源性核蛋白激酶磷酸化,并从ATP以及GTP中掺入磷酸。核蛋白和磷蛋白的磷酸化对肝素敏感,这表明它们是由酪蛋白激酶NII磷酸化的。显微注射的磷蛋白似乎并不影响ATP中的磷酸基团掺入核蛋白,但GTP介导的蛋白质磷酸化受到影响。除了32P掺入量有轻微的总体减少外,与在没有磷蛋白的情况下获得的对照值相比,一种42 kDa的核蛋白(一种假定的转录刺激因子)和一种115 kDa的核蛋白的磷酸化被竞争掉了70%-80%。对注射了磷蛋白的细胞核中的DNA转录进行的平行分析表明,RNA聚合酶II介导的hnRNA和巴尔比亚尼环RNA的合成分别减少了80%和90%。相比之下,RNA聚合酶I对核仁前核糖体38 S RNA的转录不受影响。注射前使用分离的细胞核作为蛋白激酶来源对磷蛋白进行体外磷酸化,可以逆转注射的磷蛋白的抑制作用。综上所述,结果表明特定非组蛋白的GTP依赖性磷酸化修饰与RNA聚合酶II的活性之间存在因果关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验